×

Allergan has diverse portfolio of products: Novasecta

4:06 AM ET Mon, 9 May 2016

John Rountree, partner at Novasecta, looks at anti-trust approvals and issues in the pharmaceutical sector, with specific comment on a potential deal between Teva and Allergan.